Screening for colorectal cancer using the faecal occult blood test, Hemoccult.

By P. Hewitson, P. Glasziou, L. Irwig, B. Towler, E. Watson. Cochrane Database of Systematic Reviews, 2007

679 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Cochrane Systematic Review of Colorectal Cancer Screening Using the Fecal Occult Blood Test (Hemoccult): An Update (2008, methodology): “To identify appropriate studies published, we conducted a search using Cochrane Library (2005 Version 1), MEDLINE, EMBASE, CINAHL, PsychINFO, AMED, SIGLE, and HMIC electronic databases (searches performed using WebSPIRS—full strategies used are published elsewhere (18) and are available on request).”
Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. (2008, background): “Since the last recommendation in 2002, the mortality reduction previously reported in FUBT trials was maintained in longer-term follow-up, and a recent meta-analysis estimates the overall colorectal cancer morality reduction at 15% for biennial fecal occult blood testing (21).”
Association of Colonoscopy and Death From Colorectal Cancer (2009, background): “The evidence for effectiveness of screening colonoscopy is indirect, inferred from reductions in CRC deaths in randomized trials of screening with fecal occult blood testing (12), a test that is much less sensitive than colonoscopy (13).”